Engineering nanoscale artificial antigen-presenting cells by metabolic dendritic cell labeling to potentiate cancer immunotherapy

P Xiao, J Wang, Z Zhao, X Liu, X Sun, D Wang, Y Li - Nano Letters, 2021 - ACS Publications
Nanoscale artificial antigen-presenting cells (aAPCs) are promising to activate T cells
directly for cancer immunotherapy, while feasible and flexible strategy to develop nanoscale …
被引用次数：50 相关文章

[引用][C] Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy

P Xiao, J Wang, Z Zhao, X Liu, X Sun, D Wang… - Nano …, 2021 - ui.adsabs.harvard.edu
Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling
to Potentiate Cancer Immunotherapy - NASA/ADS Now on home page ads icon ads Enable full …

Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy.

P Xiao, J Wang, Z Zhao, X Liu, X Sun, D Wang, Y Li - Nano Letters, 2021 - europepmc.org
Nanoscale artificial antigen-presenting cells (aAPCs) are promising to activate T cells
directly for cancer immunotherapy, while feasible and flexible strategy to develop nanoscale …

Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy

P Xiao, J Wang, Z Zhao, X Liu, X Sun… - Nano …, 2021 - pubmed.ncbi.nlm.nih.gov
Nanoscale artificial antigen-presenting cells (aAPCs) are promising to activate T cells
directly for cancer immunotherapy, while feasible and flexible strategy to develop nanoscale …